Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan.
Am J Ophthalmol. 2013 Dec;156(6):1169-1175.e3. doi: 10.1016/j.ajo.2013.06.035. Epub 2013 Aug 20.
To assess the extent to which incidence rates calculated for common ocular diseases by using claims data may be overestimated according to the length of the disease-free look-back period used in the analysis.
Retrospective longitudinal cohort analysis.
Billing records of 2457 persons continuously enrolled for 11 years in a managed-care network were searched for International Classification of Diseases (ICD-9-CM) diagnoses of cataract, open-angle glaucoma (OAG), nonexudative age-related macular degeneration (ARMD), and nonproliferative diabetic retinopathy (NPDR) at eye-care visits in the first half of 2001, the second half of 2010, and 2011. For each condition, incidence rates calculated by using "look-back" periods ranging from 0.5-9 years were compared with best estimates from a gold-standard period of 9.5 years.
With a 1-year disease-free look-back period, incidence was overestimated by 260% for cataract, 135% for OAG, 209% for ARMD, and 300% for NPDR. Expanding the disease-free look-back period to 3 years resulted in a reduction of incidence overestimation to 40% for cataract, 14% for OAG, 45% for ARMD, and 100% for NPDR. A 5-year look-back period yielded incidence rates that were overestimated by <30% for all 4 conditions.
In our claims-data analysis of 4 common ocular conditions, a disease-free interval ≤1 year insufficiently distinguished newly diagnosed from pre-existing disease, resulting in grossly overestimated incidence rates. Using look-back periods of 3-5 years, depending on the specific diagnosis, yielded considerably more accurate estimates of disease incidence.
评估根据分析中使用的无病回溯期的长度,通过索赔数据计算常见眼部疾病的发病率可能会被高估到何种程度。
回顾性纵向队列分析。
在管理式医疗网络中连续 11 年参保的 2457 人的计费记录中,搜索 2001 年上半年、2010 年下半年和 2011 年眼科就诊时国际疾病分类(ICD-9-CM)诊断的白内障、开角型青光眼(OAG)、非渗出性年龄相关性黄斑变性(ARMD)和非增生性糖尿病视网膜病变(NPDR)。对于每种情况,使用 0.5-9 年的“回溯”期计算的发病率与 9.5 年黄金标准期的最佳估计值进行了比较。
对于白内障,1 年无病回溯期使发病率高估了 260%;对于 OAG,发病率高估了 135%;对于 ARMD,发病率高估了 209%;对于 NPDR,发病率高估了 300%。将无病回溯期延长至 3 年,可将白内障的发病率高估率降低至 40%,OAG 的发病率高估率降低至 14%,ARMD 的发病率高估率降低至 45%,NPDR 的发病率高估率降低至 100%。对于所有 4 种疾病,5 年的无病回溯期导致发病率高估率<30%。
在我们对 4 种常见眼部疾病的索赔数据分析中,无病间隔≤1 年不能充分区分新诊断的疾病和既往存在的疾病,导致发病率被严重高估。根据特定诊断,使用 3-5 年的回溯期可以更准确地估计疾病的发病率。